ID   DCMC_HUMAN              Reviewed;         493 AA.
AC   O95822; Q9UNU5; Q9Y3F2;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 3.
DT   15-MAR-2017, entry version 149.
DE   RecName: Full=Malonyl-CoA decarboxylase, mitochondrial;
DE            Short=MCD;
DE            EC=4.1.1.9;
DE   Flags: Precursor;
GN   Name=MLYCD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CYTOPLASMIC+PEROXISOMAL),
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND INVOLVEMENT IN MLYCD
RP   DEFICIENCY.
RX   PubMed=10417274; DOI=10.1086/302492;
RA   FitzPatrick D.R., Hill A., Tolmie J.L., Thorburn D.R.,
RA   Christodoulou J.;
RT   "The molecular basis of malonyl-CoA decarboxylase deficiency.";
RL   Am. J. Hum. Genet. 65:318-326(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CYTOPLASMIC+PEROXISOMAL),
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=10455107; DOI=10.1074/jbc.274.35.24461;
RA   Sacksteder K.A., Morrell J.C., Wanders R.J.A., Matalon R., Gould S.J.;
RT   "MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA
RT   decarboxylase and is mutated in malonyl-CoA decarboxylase
RT   deficiency.";
RL   J. Biol. Chem. 274:24461-24468(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM MITOCHONDRIAL), AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=9869665;
RA   Gao J., Waber L., Bennett M.J., Gibson K.M., Cohen J.C.;
RT   "Cloning and mutational analysis of human malonyl-coenzyme A
RT   decarboxylase.";
RL   J. Lipid Res. 40:178-182(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS MITOCHONDRIAL AND
RP   CYTOPLASMIC+PEROXISOMAL).
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15003260; DOI=10.1016/j.pep.2003.11.023;
RA   Zhou D., Yuen P., Chu D., Thon V., McConnell S., Brown S., Tsang A.,
RA   Pena M., Russell A., Cheng J.F., Nadzan A.M., Barbosa M.S., Dyck J.R.,
RA   Lopaschuk G.D., Yang G.;
RT   "Expression, purification, and characterization of human malonyl-CoA
RT   decarboxylase.";
RL   Protein Expr. Purif. 34:261-269(2004).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=18314420; DOI=10.2337/db07-0583;
RA   Bouzakri K., Austin R., Rune A., Lassman M.E., Garcia-Roves P.M.,
RA   Berger J.P., Krook A., Chibalin A.V., Zhang B.B., Zierath J.R.;
RT   "Malonyl CoenzymeA decarboxylase regulates lipid and glucose
RT   metabolism in human skeletal muscle.";
RL   Diabetes 57:1508-1516(2008).
RN   [8]
RP   ASSOCIATION WITH PEX5.
RX   PubMed=20178365; DOI=10.1021/ja9109049;
RA   Ghosh D., Berg J.M.;
RT   "A proteome-wide perspective on peroxisome targeting signal 1(PTS1)-
RT   Pex5p affinities.";
RL   J. Am. Chem. Soc. 132:3973-3979(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 39-493 IN COMPLEX WITH LIGAND
RP   REPRESENTING COENZYME A, CATALYTIC ACTIVITY, FUNCTION, ENZYME
RP   REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, DISULFIDE BONDS,
RP   MUTAGENESIS OF CYS-206; CYS-243 AND GLU-302, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=23482565; DOI=10.1074/jbc.M112.443846;
RA   Aparicio D., Perez R., Carpena X., Diaz M., Ferrer J.C., Loewen P.C.,
RA   Fita I.;
RT   "Structural asymmetry and disulphide bridges among subunits modulate
RT   the activity of human Malonyl-CoA Decarboxylase.";
RL   J. Biol. Chem. 288:11907-11919(2013).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 40-490, SUBUNIT, ACTIVE SITE,
RP   AND MUTAGENESIS OF SER-290; SER-329; HIS-423 AND TYR-456.
RX   PubMed=23791943; DOI=10.1016/j.str.2013.05.001;
RA   Froese D.S., Forouhar F., Tran T.H., Vollmar M., Kim Y.S., Lew S.,
RA   Neely H., Seetharaman J., Shen Y., Xiao R., Acton T.B., Everett J.K.,
RA   Cannone G., Puranik S., Savitsky P., Krojer T., Pilka E.S., Kiyani W.,
RA   Lee W.H., Marsden B.D., von Delft F., Allerston C.K., Spagnolo L.,
RA   Gileadi O., Montelione G.T., Oppermann U., Yue W.W., Tong L.;
RT   "Crystal structures of malonyl-coenzyme A decarboxylase provide
RT   insights into its catalytic mechanism and disease-causing mutations.";
RL   Structure 21:1182-1192(2013).
CC   -!- FUNCTION: Catalyzes the conversion of malonyl-CoA to acetyl-CoA.
CC       In the fatty acid biosynthesis MCD selectively removes malonyl-CoA
CC       and thus assures that methyl-malonyl-CoA is the only chain
CC       elongating substrate for fatty acid synthase and that fatty acids
CC       with multiple methyl side chains are produced. In peroxisomes it
CC       may be involved in degrading intraperoxisomal malonyl-CoA, which
CC       is generated by the peroxisomal beta-oxidation of odd chain-length
CC       dicarboxylic fatty acids. Plays a role in the metabolic balance
CC       between glucose and lipid oxidation in muscle independent of
CC       alterations in insulin signaling. May play a role in controlling
CC       the extent of ischemic injury by promoting glucose oxidation.
CC       {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260,
CC       ECO:0000269|PubMed:18314420, ECO:0000269|PubMed:23482565}.
CC   -!- CATALYTIC ACTIVITY: Malonyl-CoA = acetyl-CoA + CO(2).
CC       {ECO:0000269|PubMed:10417274, ECO:0000269|PubMed:10455107,
CC       ECO:0000269|PubMed:15003260, ECO:0000269|PubMed:23482565,
CC       ECO:0000269|PubMed:9869665}.
CC   -!- ENZYME REGULATION: Malonyl-CoA decarboxylase activity does not
CC       require any cofactors or divalent metal ions. Formation of
CC       interchain disulfide bonds leads to positive cooperativity between
CC       active sites and increases the affinity for malonyl-CoA and the
CC       catalytic efficiency (in vitro). {ECO:0000269|PubMed:15003260,
CC       ECO:0000269|PubMed:23482565}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.36 mM for malonyl-CoA (Malonyl-CoA decarboxylase
CC         mitochondrial form), PubMed:15003260
CC         {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260,
CC         ECO:0000269|PubMed:23482565};
CC         KM=0.83 mM for malonyl-CoA (Malonyl-CoA decarboxylase
CC         mitochondrial form), PubMed:23482565
CC         {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260,
CC         ECO:0000269|PubMed:23482565};
CC         KM=0.22 mM for malonyl-CoA (Malonyl-CoA decarboxylase
CC         cytoplasmic+peroxisomal form), PubMed:10455107
CC         {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260,
CC         ECO:0000269|PubMed:23482565};
CC         KM=0.33 mM for malonyl-CoA (Malonyl-CoA decarboxylase
CC         cytoplasmic+peroxisomal form), PubMed:15003260
CC         {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260,
CC         ECO:0000269|PubMed:23482565};
CC         Note=kcat is 19 sec(-1) with malonyl-CoA for malonyl-CoA
CC         decarboxylase mitochondrial form, PubMed:15003260. kcat is 28
CC         sec(-1) with malonyl-CoA for Malonyl-CoA decarboxylase
CC         cytoplasmic+peroxisomal form, PubMed:15003260. The catalytic
CC         efficiency for malonyl-CoA is at least 1.09-fold higher with the
CC         malonyl-CoA decarboxylase cytoplasmic+peroxisomal form,
CC         PubMed:15003260.;
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; acetyl-CoA
CC       biosynthesis; acetyl-CoA from malonyl-CoA: step 1/1.
CC   -!- SUBUNIT: Homotetramer. Dimer of dimers. The two subunits within a
CC       dimer display conformational differences suggesting that at any
CC       given moment, only one of the two subunits is competent for
CC       malonyl-CoA binding and catalytic activity. Under oxidizing
CC       conditions, can form disulfide-linked homotetramers (in vitro).
CC       Associates with the peroxisomal targeting signal receptor PEX5.
CC       {ECO:0000269|PubMed:23482565, ECO:0000269|PubMed:23791943}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10417274}.
CC       Mitochondrion matrix {ECO:0000269|PubMed:10417274}. Peroxisome
CC       {ECO:0000269|PubMed:10417274}. Peroxisome matrix {ECO:0000250}.
CC       Note=Enzymatically active in all three subcellular compartments.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC         Comment=A single transcription start site has been demonstrated
CC         in Rat.;
CC       Name=Mitochondrial;
CC         IsoId=O95822-1; Sequence=Displayed;
CC       Name=Cytoplasmic+peroxisomal;
CC         IsoId=O95822-2; Sequence=VSP_047649;
CC         Note=May be produced by alternative initiation at Met-40 of
CC         isoform mitochondrial. Alternatively, represents a proteolytic
CC         processed form of the mitochondrial form.;
CC   -!- TISSUE SPECIFICITY: Expressed in fibroblasts and hepatoblastoma
CC       cells (at protein level). Expressed strongly in heart, liver,
CC       skeletal muscle, kidney and pancreas. Expressed in myotubes.
CC       Expressed weakly in brain, placenta, spleen, thymus, testis, ovary
CC       and small intestine. {ECO:0000269|PubMed:10455107,
CC       ECO:0000269|PubMed:18314420}.
CC   -!- PTM: Acetylation at Lys-472 activates malonyl-CoA decarboxylase
CC       activity. Deacetylation at Lys-472 by SIRT4 represses activity,
CC       leading to promote lipogenesis (By similarity). {ECO:0000250}.
CC   -!- PTM: Interchain disulfide bonds may form in peroxisomes
CC       (Potential). Interchain disulfide bonds are not expected to form
CC       in the reducing environment of the cytoplasm and mitochondria.
CC       {ECO:0000305}.
CC   -!- DISEASE: Malonyl-CoA decarboxylase deficiency (MLYCD deficiency)
CC       [MIM:248360]: Autosomal recessive disease characterized by
CC       abdominal pain, chronic constipation, episodic vomiting, metabolic
CC       acidosis and malonic aciduria. {ECO:0000269|PubMed:10417274}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD16177.2; Type=Frameshift; Positions=23, 28, 297, 308; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF097832; AAD16177.2; ALT_FRAME; mRNA.
DR   EMBL; AF153679; AAD34631.1; -; mRNA.
DR   EMBL; AF090834; AAD48994.1; -; mRNA.
DR   EMBL; AC009119; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000286; AAH00286.1; -; mRNA.
DR   EMBL; BC052592; AAH52592.1; -; mRNA.
DR   CCDS; CCDS42206.1; -. [O95822-1]
DR   RefSeq; NP_036345.2; NM_012213.2. [O95822-1]
DR   UniGene; Hs.644610; -.
DR   PDB; 2YGW; X-ray; 2.80 A; A/B=40-490.
DR   PDB; 4F0X; X-ray; 3.29 A; A/B/C/D/E/F/G/H=39-493.
DR   PDBsum; 2YGW; -.
DR   PDBsum; 4F0X; -.
DR   ProteinModelPortal; O95822; -.
DR   SMR; O95822; -.
DR   BioGrid; 116989; 10.
DR   DIP; DIP-60405N; -.
DR   IntAct; O95822; 3.
DR   STRING; 9606.ENSP00000262430; -.
DR   BindingDB; O95822; -.
DR   ChEMBL; CHEMBL4698; -.
DR   GuidetoPHARMACOLOGY; 1275; -.
DR   SwissLipids; SLP:000000251; -.
DR   iPTMnet; O95822; -.
DR   PhosphoSitePlus; O95822; -.
DR   BioMuta; MLYCD; -.
DR   EPD; O95822; -.
DR   MaxQB; O95822; -.
DR   PaxDb; O95822; -.
DR   PeptideAtlas; O95822; -.
DR   PRIDE; O95822; -.
DR   Ensembl; ENST00000262430; ENSP00000262430; ENSG00000103150. [O95822-1]
DR   GeneID; 23417; -.
DR   KEGG; hsa:23417; -.
DR   UCSC; uc002fgz.4; human. [O95822-1]
DR   CTD; 23417; -.
DR   DisGeNET; 23417; -.
DR   GeneCards; MLYCD; -.
DR   H-InvDB; HIX0173296; -.
DR   HGNC; HGNC:7150; MLYCD.
DR   HPA; HPA031625; -.
DR   MalaCards; MLYCD; -.
DR   MIM; 248360; phenotype.
DR   MIM; 606761; gene.
DR   neXtProt; NX_O95822; -.
DR   OpenTargets; ENSG00000103150; -.
DR   Orphanet; 943; Malonic aciduria.
DR   PharmGKB; PA30861; -.
DR   eggNOG; KOG3018; Eukaryota.
DR   eggNOG; COG1593; LUCA.
DR   GeneTree; ENSGT00390000005410; -.
DR   HOGENOM; HOG000141409; -.
DR   HOVERGEN; HBG000825; -.
DR   InParanoid; O95822; -.
DR   KO; K01578; -.
DR   OMA; LDEGREQ; -.
DR   OrthoDB; EOG091G07WG; -.
DR   PhylomeDB; O95822; -.
DR   TreeFam; TF312959; -.
DR   BRENDA; 4.1.1.9; 2681.
DR   Reactome; R-HSA-390918; Peroxisomal lipid metabolism.
DR   SABIO-RK; O95822; -.
DR   UniPathway; UPA00340; UER00710.
DR   ChiTaRS; MLYCD; human.
DR   GenomeRNAi; 23417; -.
DR   PRO; PR:O95822; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103150; -.
DR   CleanEx; HS_MLYCD; -.
DR   Genevisible; O95822; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005782; C:peroxisomal matrix; ISS:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0050080; F:malonyl-CoA decarboxylase activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0006085; P:acetyl-CoA biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006637; P:acyl-CoA metabolic process; TAS:Reactome.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:2001294; P:malonyl-CoA catabolic process; IDA:UniProtKB.
DR   GO; GO:0046321; P:positive regulation of fatty acid oxidation; IMP:UniProtKB.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB.
DR   GO; GO:0002931; P:response to ischemia; ISS:UniProtKB.
DR   InterPro; IPR007956; Malonyl_CoA_deC.
DR   Pfam; PF05292; MCD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Alternative splicing; Complete proteome; Cytoplasm; Decarboxylase;
KW   Disulfide bond; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Lyase; Mitochondrion;
KW   Peroxisome; Reference proteome; Transit peptide.
FT   TRANSIT       1     39       Mitochondrion. {ECO:0000255}.
FT   CHAIN        40    493       Malonyl-CoA decarboxylase, mitochondrial.
FT                                /FTId=PRO_0000021088.
FT   REGION       40    190       Alpha-helical domain.
FT   REGION      191    493       Catalytic domain.
FT   REGION      299    305       Malonyl-CoA binding. {ECO:0000305}.
FT   MOTIF       491    493       Microbody targeting signal.
FT                                {ECO:0000255}.
FT   ACT_SITE    329    329       Proton acceptor.
FT                                {ECO:0000305|PubMed:23791943}.
FT   ACT_SITE    423    423       Proton donor.
FT                                {ECO:0000305|PubMed:23791943}.
FT   BINDING     329    329       Malonyl-CoA. {ECO:0000305}.
FT   BINDING     423    423       Malonyl-CoA. {ECO:0000305}.
FT   SITE        211    211       Essential for catalytic activity.
FT                                {ECO:0000250}.
FT   MOD_RES      59     59       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99J39}.
FT   MOD_RES     168    168       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99J39}.
FT   MOD_RES     168    168       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99J39}.
FT   MOD_RES     211    211       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99J39}.
FT   MOD_RES     222    222       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99J39}.
FT   MOD_RES     389    389       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99J39}.
FT   MOD_RES     472    472       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99J39}.
FT   DISULFID    206    206       Interchain. {ECO:0000255}.
FT   VAR_SEQ       1     39       Missing (in isoform
FT                                Cytoplasmic+peroxisomal).
FT                                {ECO:0000303|PubMed:10417274,
FT                                ECO:0000303|PubMed:10455107,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_047649.
FT   MUTAGEN     206    206       C->S: Abolishes formation of disulfide-
FT                                linked homotetramers. Abolishes the
FT                                cooperative enzyme kinetics that are seen
FT                                under oxidative conditions.
FT                                {ECO:0000269|PubMed:23482565}.
FT   MUTAGEN     243    243       C->S: Does not abolish formation of
FT                                disulfide-linked homotetramers. No effect
FT                                on development of cooperative enzyme
FT                                kinetics in response to oxidative
FT                                conditions.
FT                                {ECO:0000269|PubMed:23482565}.
FT   MUTAGEN     290    290       S->F: 2-fold reduction in catalytic
FT                                activity. {ECO:0000269|PubMed:23791943}.
FT   MUTAGEN     302    302       E->G: Decreases catalytic activity.
FT                                Increases affinity for malonyl-CoA.
FT                                {ECO:0000269|PubMed:23482565}.
FT   MUTAGEN     329    329       S->A: 110-fold reduction in catalytic
FT                                activity. {ECO:0000269|PubMed:23791943}.
FT   MUTAGEN     423    423       H->N: 7-fold reduction in catalytic
FT                                activity. {ECO:0000269|PubMed:23791943}.
FT   MUTAGEN     456    456       Y->S: 3.5-fold reduction in catalytic
FT                                activity. {ECO:0000269|PubMed:23791943}.
FT   CONFLICT     82     82       A -> D (in Ref. 1; AAD16177).
FT                                {ECO:0000305}.
FT   CONFLICT    119    119       A -> S (in Ref. 3; AAD48994).
FT                                {ECO:0000305}.
FT   CONFLICT    127    127       D -> V (in Ref. 3; AAD48994).
FT                                {ECO:0000305}.
FT   CONFLICT    192    192       S -> P (in Ref. 2; AAD34631).
FT                                {ECO:0000305}.
FT   HELIX        40     47       {ECO:0000244|PDB:2YGW}.
FT   HELIX        54     56       {ECO:0000244|PDB:2YGW}.
FT   HELIX        67     76       {ECO:0000244|PDB:2YGW}.
FT   HELIX        81     94       {ECO:0000244|PDB:2YGW}.
FT   HELIX        99    112       {ECO:0000244|PDB:2YGW}.
FT   TURN        114    116       {ECO:0000244|PDB:4F0X}.
FT   HELIX       119    132       {ECO:0000244|PDB:2YGW}.
FT   HELIX       138    145       {ECO:0000244|PDB:2YGW}.
FT   STRAND      147    149       {ECO:0000244|PDB:4F0X}.
FT   HELIX       150    166       {ECO:0000244|PDB:2YGW}.
FT   HELIX       173    189       {ECO:0000244|PDB:2YGW}.
FT   HELIX       192    194       {ECO:0000244|PDB:2YGW}.
FT   STRAND      195    200       {ECO:0000244|PDB:2YGW}.
FT   HELIX       206    214       {ECO:0000244|PDB:2YGW}.
FT   HELIX       224    230       {ECO:0000244|PDB:2YGW}.
FT   STRAND      235    242       {ECO:0000244|PDB:2YGW}.
FT   STRAND      250    260       {ECO:0000244|PDB:2YGW}.
FT   HELIX       266    269       {ECO:0000244|PDB:2YGW}.
FT   STRAND      285    294       {ECO:0000244|PDB:2YGW}.
FT   HELIX       296    298       {ECO:0000244|PDB:2YGW}.
FT   TURN        299    301       {ECO:0000244|PDB:4F0X}.
FT   HELIX       303    318       {ECO:0000244|PDB:2YGW}.
FT   STRAND      324    327       {ECO:0000244|PDB:2YGW}.
FT   HELIX       334    341       {ECO:0000244|PDB:2YGW}.
FT   STRAND      348    350       {ECO:0000244|PDB:4F0X}.
FT   HELIX       357    367       {ECO:0000244|PDB:4F0X}.
FT   HELIX       374    379       {ECO:0000244|PDB:2YGW}.
FT   TURN        380    382       {ECO:0000244|PDB:2YGW}.
FT   HELIX       383    386       {ECO:0000244|PDB:2YGW}.
FT   HELIX       388    393       {ECO:0000244|PDB:2YGW}.
FT   HELIX       395    407       {ECO:0000244|PDB:2YGW}.
FT   STRAND      414    417       {ECO:0000244|PDB:2YGW}.
FT   HELIX       418    425       {ECO:0000244|PDB:2YGW}.
FT   STRAND      429    434       {ECO:0000244|PDB:2YGW}.
FT   HELIX       441    447       {ECO:0000244|PDB:2YGW}.
FT   STRAND      451    455       {ECO:0000244|PDB:2YGW}.
FT   HELIX       458    460       {ECO:0000244|PDB:2YGW}.
FT   HELIX       461    471       {ECO:0000244|PDB:2YGW}.
FT   HELIX       478    486       {ECO:0000244|PDB:2YGW}.
SQ   SEQUENCE   493 AA;  55003 MW;  8F061CA38908E8FC CRC64;
     MRGFGPGLTA RRLLPLRLPP RPPGPRLASG QAAGALERAM DELLRRAVPP TPAYELREKT
     PAPAEGQCAD FVSFYGGLAE TAQRAELLGR LARGFGVDHG QVAEQSAGVL HLRQQQREAA
     VLLQAEDRLR YALVPRYRGL FHHISKLDGG VRFLVQLRAD LLEAQALKLV EGPDVREMNG
     VLKGMLSEWF SSGFLNLERV TWHSPCEVLQ KISEAEAVHP VKNWMDMKRR VGPYRRCYFF
     SHCSTPGEPL VVLHVALTGD ISSNIQAIVK EHPPSETEEK NKITAAIFYS ISLTQQGLQG
     VELGTFLIKR VVKELQREFP HLGVFSSLSP IPGFTKWLLG LLNSQTKEHG RNELFTDSEC
     KEISEITGGP INETLKLLLS SSEWVQSEKL VRALQTPLMR LCAWYLYGEK HRGYALNPVA
     NFHLQNGAVL WRINWMADVS LRGITGSCGL MANYRYFLEE TGPNSTSYLG SKIIKASEQV
     LSLVAQFQKN SKL
//
